Health Chiefs Warn Deadly Meningitis B Strain Mutation Could Be Fuelling Rapid Spread
Health authorities have issued a stark warning that a deadly meningitis B strain may have evolved, potentially driving a rapid and unusual spread of the illness. The outbreak, centred in Kent, has now seen cases rise to 29, according to the UK Health Security Agency (UKHSA), up from 27 previously reported. In response, extensive public health measures have been deployed, including 2,360 vaccinations and 9,840 doses of antibiotics administered to those affected.
Unusual Nature of the Canterbury Outbreak
The outbreak in Canterbury is considered highly unusual by scientists, as meningitis infections typically occur as isolated, one-off cases. On average, the UK records just one case per day, making this cluster particularly alarming. Health officials have taken samples from patients in hospitals to analyse the bacteria in laboratory settings. Using advanced genome sequencing techniques, they aim to pinpoint the specific variant of the meningitis B strain responsible.
Professor Robin May, chief scientific officer at the UKHSA, highlighted the rarity of such a large number of cases stemming from a single event. He explained to The Times that there are two primary hypotheses for this surge. One possibility involves behavioural factors among individuals, while the other suggests the bacteria itself may have evolved to become more transmissible.
Concerns Over Strain Mutations and Severity
Dr Michael Head, a senior research fellow in global health at the University of Southampton, emphasised that insufficient knowledge exists about this particular type of meningitis B. He raised concerns that mutations might be causing more severe illness, stating, "It's a tricky pathogen to handle because there are so many different types, and there may be something about this specific serotype in this outbreak that is causing it to behave differently, which is why we're seeing so many severe cases."
Despite these worries, health chiefs have reassured the public that the Bexsero vaccine, used to protect against meningitis B, should provide effective protection against the strain identified in this outbreak. The UKHSA confirmed in a statement that initial genetic analysis has shown the strain belongs to a group of bacteria known as group B meningococci, sequence type 485, part of the larger clonal complex ST-41/44. Similar strains have been circulating in the UK for approximately five years, but detailed analysis of the outbreak pathogen is ongoing.
Vaccination Rollout and Family Appeals
The UKHSA is publishing available data to enable national and international partners to conduct further scientific research. This comes amid heartfelt appeals from families affected by the outbreak. The family of 18-year-old Juliette Kenny, one of two young people confirmed to have died, has called for a mass rollout of the vaccination. They have joined growing calls to extend NHS access for the menB vaccine to teenagers and young adults.
Currently, the meningitis B vaccine is being administered to students and staff at the University of Kent and individuals offered preventative antibiotics as part of the outbreak response. While the vaccine has been available on the NHS since 2015 as part of routine childhood immunisations for babies, this means many schoolchildren and university students remain unvaccinated against the menB strain, highlighting potential gaps in coverage.
